Axsome Therapeutics AXSM
NASDAQ AXSM
$178.26 -3.81 (-2.09%)
As of: Oct 2, 2026 · 3:32 PM EDT

Axsome Therapeutics (AXSM) Cash from Financing Activities (2015 - 2026)

Updated

Axsome Therapeutics' Cash from Financing Activities came in at $48.15 million for Q2 2026, up 39.4% from $34.54 million a year earlier.

Analysis

Axsome Therapeutics (AXSM) Cash from Financing Activities (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Axsome Therapeutics reported Cash from Financing Activities of $88.79 million, down 18.1% year-over-year; for FY2025, it was $101.47 million, up 75.4% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $57.84 million in FY2024 (-82.5%), $331.01 million in FY2023 (+16.3%), $284.58 million in FY2022 and $11.13 million in FY2021 (-73.8%).
  • The Q2 2026 figure represents the highest quarterly Cash from Financing Activities since Q2 2023.
  • Year-over-year, Cash from Financing Activities increased in three of the last six quarters, with growth averaging 11.0%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2022 (growth of 287.4%), and the weakest in Q3 2021 (a decline of 98.4%).
  • Business Quant data shows AXSM's Cash from Financing Activities at $2.99 million (Q1 2026), $16.39 million (Q4 2025) and $21.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Axsome Therapeutics 9.64 Bn 8.37 Bn 204.81 Mn 48.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.15 Mn
Mar 31, 2026 2.99 Mn
Dec 31, 2025 16.39 Mn
Sep 30, 2025 21.27 Mn
Jun 30, 2025 34.54 Mn
Mar 31, 2025 29.27 Mn
Dec 31, 2024 14.24 Mn
Sep 30, 2024 30.41 Mn
Jun 30, 2024 14.38 Mn
Mar 31, 2024 -1.19 Mn
Dec 31, 2023 -2,000.00
Sep 30, 2023 33.37 Mn
Jun 30, 2023 246.08 Mn
Mar 31, 2023 51.57 Mn
Dec 31, 2022 1.07 Mn
Sep 30, 2022 176.95 Mn
Jun 30, 2022 75.46 Mn
Mar 31, 2022 31.10 Mn
Dec 31, 2021 690,766.00
Sep 30, 2021 438,683.00
API Access

Axsome Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AXSM&period=max&api_key=YOUR_API_KEY